MRMihir Prafulbhai Rupani

Mihir Prafulbhai Rupani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mihir Prafulbhai Rupani has a total of 82 co-authors. Here are the top co-authors by number of shared publications:

  • Sheetal Vyas

    Gujarat University, Ahmedabad, India

    5 shared publications
  • Jigna D. Dave

    Department of Respiratory Medicine, Government Medical College, Bhavnagar, Gujarat, India

    4 shared publications
  • Khushali Dharmesh Parikh

    Department of Pathology, Government Medical College Bhavnagar (Maharaja Krishnakumarsinhji Bhavnagar University), Bhavnagar, India

    4 shared publications
  • Bhavesh V. Modi

    Health Sciences Division, ICMR-National Institute of Occupational Health, Ahmedabad, India

    2 shared publications
  • Deizy R. Nimavat

    Health Sciences Division, ICMR-National Institute of Occupational Health, Ahmedabad, India

    2 shared publications
  • Gitika Kharkwal

    Biological Sciences Division, ICMR-National Institute of Occupational Health, Ahmedabad, India

    2 shared publications

Latest Publications

  • Open Access

    Respirable crystalline silica exposure in agate-stone workers in Khambhat, India: a human health risk assessment using a probabilistic approach

    by Muskan Saini, Nikhil P. Kulkarni, Rakesh Balachandar, Gitika Kharkwal, Rutu N. Asodia, Krishna K. Vaghela, Deizy R. Nimavat, Nitishkumar D. Tank, P. Sivaperumal, Mihir P. Rupani, et al.

  • A Cross-Sectional Study Assessing Pulmonary Function Differences in Diabetic Versus Non-Diabetic Mine Workers in Gujarat: Implications for Establishing Mining Cohort

    by Nitishkumar D. Tank, Mihir P. Rupani, Rakshit B. Shah, Sarang V. Dhatrak

    Background: Diabetes, a significant global health concern, affects one in 10 adults, with many unaware. Despite its prevalence, evidence on its impact on pulmonary function is limited. Given the occupational exposure to silica dust, mine workers may face heightened pulmonary risks with diabetes. Our objective was to estimate differences in pulmonary functions between diabetic and non-diabetic mine workers and determine predictors of pulmonary dysfunction. Methods: We conducted a cross-sectional study of 215 mine workers from Gujarat’s lignite mines in December 2021. Data on demographics, occupation, comorbidities, anthropometry, blood pressure, and random blood glucose (RBG) were collected. Diabetes was defined as self-reported history or RBG ≥200 mg/dL with symptoms. Spirometry measured forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC). Group differences were analyzed using independent t -tests, and linear regression identified predictors of pulmonary function. Findings: Diabetic workers (18%) exhibited lower FEV 1 (2.80 ± 0.65 vs. 3.11 ± 0.77 L, p = .022) and FVC (3.21 ± 0.69 vs. 3.55 ± 0.84 L, p = .017). On linear regression, male gender and longer work experience significantly predicted FEV 1 and FVC, while adjustments for confounding variables diminished diabetes’s impact. Conclusion: Lower FEV 1 and FVC among diabetic mine workers suggest a potential role of diabetes in pulmonary impairment. The diminished effect after adjustment underscores the need for mining cohorts to confirm these findings. Application to Practice: Mine workers should undergo annual diabetes screening and respiratory evaluations beyond routine periodic medical examinations. Workplace programs targeting non-communicable diseases should be implemented to support long-term worker health.


  • Open Access

    Use of smokeless tobacco by patients with drug-sensitive pulmonary tuberculosis: The need for strengthening tuberculosis–tobacco collaborative in India

    by Antara Banik, Mihir P. Rupani, Atulkumar V. Trivedi, Jigna D. Dave

    Background: A joint tuberculosis–tobacco collaborative was launched in India in 2017 to reduce the addictive habit of tobacco use among patients with tuberculosis (TB). We aimed to estimate the prevalence and predictors of smokeless tobacco use and its awareness among patients with pulmonary TB in Bhavnagar city, Gujarat, India. Methods: We did a cross-sectional study among 258 randomly selected drug-sensitive pulmonary TB patients registered at the District TB Centre in Bhavnagar from April to October 2019. The Global Adult Tobacco Survey questionnaire was used for data collection. Multivariable logistic regression was used to determine the predictors of smokeless tobacco use. Results: Among the 258 patients, 73% were male, 66% were married, 40% traveled for their occupation, 62% had a nuclear family, and 46% were illiterate. More than half (52%) the patients used smokeless tobacco: 44% were daily users and 8% were occasional users. On multivariable logistic regression, male gender (adjusted odds ratio [aOR]: 5 [95% confidence interval (CI) 2–11]), occupation requiring travel (aOR: 4 [95% CI: 2–7]), monthly income of ₹3001–6000 (aOR: 0.2 [95% CI: 0.1–0.6]), ₹9000–12 000 (aOR: 0.3 [95% CI: 0.1–0.9]) and above ₹12 000 (aOR: 0.3 [95% CI: 0.1–0.8]) were significant predictors of smokeless tobacco use. Almost all (98%) of the participants were aware of the harmful effects of smokeless tobacco on health. Conclusion: More than half the patients with pulmonary TB used smokeless tobacco. The TB–tobacco collaborative framework needs to be strengthened with brief counselling interventions for patients with TB using smokeless tobacco for collateral benefits in the control of TB in India.

  • Open Access

    Exploring the impact of national laboratory accreditation on quality and practices: a qualitative study from a government medical college in western India

    by Khushali D. Parikh, Mihir P. Rupani

    Medical laboratories play a crucial role in diagnostics and therapeutic decisions, with accreditation by bodies like the National Accreditation Board for Testing and Calibration Laboratories (NABL) ensuring technical competence. This study examines the impact of NABL accreditation on laboratory practices, highlighting benefits, challenges, and areas for improvement. This qualitative study used six focus group discussions (FGDs) and five in-depth interviews (IDIs) to explore experiences of laboratory professionals at NABL-accredited laboratories in Government Medical College, Bhavnagar, Gujarat. Participants were purposively selected to ensure diverse perspectives. Thematic analysis, employing an inductive approach, was validated through member checking. The 29 participants reported NABL accreditation positively influenced quality control, standard adherence, and accuracy of laboratory reports. Maintenance of quality registers, equipment calibration, adherence to standard operating procedures (SOPs), and participation in External Quality Assessment Schemes (EQAS) promoted continuous improvement. However, significant challenges included excessive documentation, subjective assessments, workflow disruptions, and financial constraints. Participants recognized accreditation’s educational value, skill enhancement opportunities, and improved market credibility. Recommended improvements included digital documentation systems, reduced administrative burdens, clearer assessment criteria, and increased clinician involvement. NABL accreditation significantly elevates laboratory standards, improving patient care and clinical decision-making. However, challenges such as excessive paperwork, subjective assessments, financial constraints, and data integrity issues must be addressed. Digital documentation systems, unannounced inspections, clearer assessor guidelines, and greater clinician engagement could mitigate these barriers. Accreditation also enhances educational outcomes and market perception. Policymakers and accreditation bodies should incorporate these findings to refine accreditation processes and sustainably improve laboratory quality and healthcare outcomes.


  • Open Access

    Survival analysis shows tuberculosis patients with silicosis experience earlier mortality and need employer-led care models in occupational settings in India

    by Mihir P. Rupani, Soundarya Soundararajan

    India’s high tuberculosis (TB) burden is exacerbated by concurrent silicosis, which increases TB susceptibility and worsens treatment outcomes. Limited studies on TB patients with silicosis highlight the need to address this vulnerable group’s specific challenges, particularly to improve diagnosis and management. This retrospective cohort study analyzed survival data from 137 silico-tuberculosis and 2,605 TB-only patients in Khambhat, India, using Kaplan-Meier curves, log-rank tests, and comparisons between Cox proportional hazards and accelerated failure time (AFT) models. The lognormal AFT model, selected for its lowest Akaike Information Criterion (AIC), estimated survival times based on age, gender, HIV status, and prior TB treatment. Among the 2,742 patients, 309 (11%) died within 27 months. Median time from diagnosis to outcome was shorter for deceased patients (1.7 months) than for censored patients (5.6 months, p < 0.001, median test). Kaplan-Meier analysis showed a significantly steeper survival decline for silico-tuberculosis patients (p < 0.001, log-rank test). Silico-tuberculosis was associated with a two-fold increased mortality risk (HR = 2.0, 95% CI: 1.4-3.0, p < 0.001, Cox-proportional hazards regression). The lognormal AFT model indicated silico-tuberculosis patients had 36% of the median survival time compared to TB-only patients (16 vs. 44 months). These findings highlight significantly earlier mortality in silico-tuberculosis patients, underscoring the need for targeted, employer-led care models and TB-silicosis collaborative screening within India’s TB program for high-risk occupational groups.


  • Open Access

    Silicosis predicts drug resistance and retreatment among tuberculosis patients in India: a secondary data analysis from Khambhat, Gujarat (2006–2022)

    by Mihir P. Rupani

    India, with the highest global burden of tuberculosis (TB) and drug-resistant TB, aims to eliminate TB by 2025. Yet, limited evidence exists on drug resistance patterns and retreatment among patients with silico-tuberculosis. This study explores these patterns and assesses the impact of silicosis on TB retreatment in India. This secondary data analysis stems from a larger retrospective cohort study conducted in Khambhat, Gujarat, between January 2006 and February 2022. It included 138 patients with silico-tuberculosis and 2,610 TB patients without silicosis. Data from the Nikshay TB information portal were linked with silicosis diagnosis reports from the Pneumoconiosis Board using the unique Nikshay ID as the linking variable. Drug-resistant TB was defined as resistance to any anti-TB drug recorded in Nikshay. Retreatment refers to TB patients who have previously undergone anti-TB treatment for one month or more and need further treatment. Recurrent TB denotes patients who were previously declared cured or had completed treatment but later tested positive for microbiologically confirmed TB. Multivariable logistic regression was used to determine the impact of co-prevalent silicosis on drug resistance and retreatment. Patients with silico-tuberculosis showed a higher proportion of retreatment compared to those without silicosis (55% vs. 23%, p < 0.001). Notably, 28% of patients with silico-tuberculosis were recurrent TB cases, compared to 11% among those without silicosis. Regarding drug resistance, the silico-tuberculosis group exhibited a higher rate (6% vs. 3%), largely due to rifampicin resistance (5% vs. 2%, p = 0.022). Co-prevalent silicosis was associated with a 2.5 times greater risk of drug-resistant TB (adjusted OR 2.5, 95% CI, 1.1–5.3; p = 0.021). Additionally, patients with silico-tuberculosis had a fourfold increased risk of retreatment for TB (adjusted OR 4, 95% CI, 3–6; p < 0.001). Co-prevalent silicosis significantly elevates the risk of drug resistance, recurrence, and retreatment among TB patients in India. This study indicates a need for improved treatment protocols and suggests that future research should focus on randomized controlled trials to evaluate appropriate anti-TB regimen and duration of therapy for this high-risk group. Given India’s goal to eliminate TB by 2025, addressing the challenges posed by silico-tuberculosis is critical.


  • Open Access

    Cohort study on association between catastrophic costs and unfavorable tuberculosis treatment outcomes among TB-HIV and TB-diabetes comorbid patients in India

    by Mihir P. Rupani, Sheetal Vyas, Immad A. Shah

    India grapples with an alarming burden of tuberculosis (TB), reporting 2.6 million incident cases in 2023, necessitating intensified efforts toward TB elimination. The prevalence of catastrophic costs, defined as expenses exceeding 20% of annual household income, varies widely. Our objective was to determine the association between catastrophic costs from TB-HIV and TB-diabetes care and unfavorable TB treatment outcomes. We conducted a cohort study in Bhavnagar, India, from July 2019 to January 2021, involving 234 TB-HIV and 304 TB-diabetes patients. Catastrophic costs were assessed using the World Health Organization’s tool. Unfavorable TB treatment outcomes included positive results from sputum smear, nucleic acid amplification, or culture tests at treatment completion, death during treatment, or treatment cessation for a month (for drug-sensitive TB) or two months (for drug-resistant TB). Firth regression was employed to address quasi-separation issues and identify predictors. Among TB-HIV patients, 12% faced catastrophic costs, with 20% experiencing unfavorable TB outcomes. In this group, significant predictors included weight (OR: 0.93, 95% CI: 0.89–0.98), family type (OR: 2.5, 95% CI: 1.2–5.5), and initial hospitalization (OR: 2.6, 95% CI: 1.1–6.3). For TB-diabetes patients, 5% faced catastrophic costs, and 14% had unfavorable outcomes, with significant predictors being below the poverty line (BPL) (OR: 2.9, 95% CI: 1.5–5.9) and initial hospitalization (OR: 3.4, 95% CI: 1.1–11.1). Catastrophic cost incidence was higher in TB-HIV (12% vs. 4% in TB only) and TB-diabetes (5% vs. 4% in TB only) patients. However, catastrophic costs did not show a direct association with unfavorable outcomes in either group. Our study found no direct association between catastrophic costs and unfavorable TB outcomes among TB-HIV/TB-diabetes patients. Instead, factors such as weight, family type, BPL status, and initial hospitalization were significant predictors. These findings underscore the importance of socio-economic conditions and initial hospitalization, advocate for enhanced support mechanisms including nutritional and financial aid, especially for BPL families.


  • Open Access

    Estimating HIV Disclosure and Its Impact on Social Relations: A Cross-Sectional Study in Gujarat, India

    by Khushali D Parikh, Mihir Rupani

    Background: The disclosure of HIV-positive status can significantly impact social relationships. This study aimed to evaluate the prevalence of self-disclosure of HIV status and its effects on social relations among individuals living with HIV (PLHIV) in Gujarat, India. Methods: Conducted from April to June 2021, this cross-sectional study involved 383 PLHIV attending a tertiary-care medical college hospital in Gujarat, India. The sample size was determined using Epi Info software version 7. Data collection utilized a structured questionnaire covering socio-demographic information, HIV disclosure status, and its impact on social relationships. Multiple logistic regression analysis identified predictors of non-disclosure of HIV status to spouses. Results: Among the 383 participants, 83% disclosed their HIV status to their spouse, while disclosure rates to other social contacts varied. Post-disclosure, 7% reported strained or broken relationships with their spouses. Factors associated with non-disclosure to spouses included older age (adjusted odds ratio [aOR] 1.13, 95% confidence interval [CI] 1.07-1.20), female gender (aOR 6.00, 95% CI 1.81-19.88), lack of post-test counselling (aOR 3.29, 95% CI 1.01-10.70), and spouse being HIV-negative (aOR 3.60, 95% CI 1.27-10.25). Conclusion: In conclusion, while a significant proportion of PLHIV disclosed their HIV status to spouses, a notable proportion experienced strained relationships post-disclosure. Addressing barriers to disclosure, especially among older individuals and females, and ensuring adequate post-test counselling, may facilitate open communication and support among PLHIV and their social networks.

  • Open Access

    A mixed-methods study on impact of active case finding on pulmonary tuberculosis treatment outcomes in India

    by Akshat P. Shah, Jigna D. Dave, Mohit N. Makwana, Mihir P. Rupani, Immad A. Shah

    Background: Tuberculosis (TB) remains a significant public health burden in India, with elimination targets set for 2025. Active case finding (ACF) is crucial for improving TB case detection rates, although conclusive evidence of its association with treatment outcomes is lacking. Our study aims to investigate the impact of ACF on successful TB treatment outcomes among pulmonary TB patients in Gujarat, India, and explore why ACF positively impacts these outcomes. Methods: We conducted a retrospective cohort analysis in Gujarat, India, including 1,638 pulmonary TB cases identified through ACF and 80,957 cases through passive case finding (PCF) from January 2019 to December 2020. Generalized logistic mixed-model compared treatment outcomes between the ACF and PCF groups. Additionally, in-depth interviews were conducted with 11 TB program functionaries to explore their perceptions of ACF and its impact on TB treatment outcomes. Results: Our analysis revealed that patients diagnosed through ACF exhibited 1.4 times higher odds of successful treatment outcomes compared to those identified through PCF. Program functionaries emphasized that ACF enhances case detection rates and enables early detection and prompt treatment initiation. This early intervention facilitates faster sputum conversion and helps reduce the infectious period, thereby improving treatment outcomes. Functionaries highlighted that ACF identifies TB cases that might otherwise be missed, ensuring timely and appropriate treatment. Conclusion: ACF significantly improves TB treatment outcomes in Gujarat, India. The mixed-methods analysis demonstrates a positive association between ACF and successful TB treatment, with early detection and prompt treatment initiation being key factors. Insights from TB program functionaries underscore the importance of ACF in ensuring timely diagnosis and treatment, which are critical for better treatment outcomes. Expanding ACF initiatives, especially among hard-to-reach populations, can further enhance TB control efforts. Future research should focus on optimizing ACF strategies and integrating additional interventions to sustain and improve TB treatment outcomes.


  • Open Access

    Framework for implementing collaborative TB-silicosis activities in India: insights from an expert panel

    by Mihir P. Rupani, Pankaj Nimavat, Yogesh Patel, Harsh D. Shah, Arkaprabha Sau

    Tuberculosis (TB) treatment is more challenging for patients with silicosis, as it complicates the diagnosis of both diseases and increases mortality risk. Silicosis, an incurable occupational disease, confounds the diagnosis of TB and vice versa, making it more difficult to accurately identify and treat either condition. Moreover, TB appears to accelerate the progression of silicosis. Exposure to silica dust, a common cause of silicosis, can also trigger latent TB to become active TB. This correspondence outlines a proposed framework for implementing collaborative TB-silicosis activities in India, aimed at improving early diagnosis and management for both diseases. An expert panel of medical professionals developed this framework through online consultations in October and November 2022. The panel's goal was to establish a consensus on integrating TB-silicosis activities, with a focus on early detection and proper management. The framework suggests testing all patients with silicosis for active TB and screening workers exposed to silica dust for latent TB infection. It also recommends that patients with TB who have a history of occupational exposure to silica dust should be tested for silicosis. Reliable diagnostic tools, such as chest X-rays, are emphasized, providing guidance on their use for both diseases. The proposed collaborative TB-silicosis framework offers a structured approach to identifying and managing these two diseases, contributing to the global goal of eliminating silicosis by 2030 and aligning with the World Health Organization’s targets for reducing TB incidence and mortality. It recommends specific strategies for implementation, including testing, referral systems, and workplace-based interventions. The framework also underscores the need for coordinated efforts among stakeholders, including the ministries of health, labor, industry, and environment. This correspondence provides valuable insights into how India can successfully implement collaborative TB-silicosis activities, serving as a model for other regions with similar challenges.